Lo Castro, Flavia
Lo Castro, Flavia
Allopregnanolone serum levels in female migraineurs
2019 Rustichelli, C.; Bellei, E.; Bergamini, S.; Monari, E.; Lo Castro, F.; Baraldi, C.; Cainazzo, M. M.; Tomasi, A.; Ferrari, A.
Chronic migraine evolution after 3 months from erenumab suspension: real-world-evidence-life data
2022 Guerzoni, S.; Baraldi, C.; Pensato, U.; Favoni, V.; Lo Castro, F.; Cainazzo, M. M.; Cevoli, S.; Pani, L.
Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study
2021 Rustichelli, Cecilia; Bellei, Elisa; Bergamini, Stefania; Monari, Emanuela; Lo Castro, Flavia; Baraldi, Carlo; Tomasi, Aldo; Ferrari, Anna
OnabotulinumtoxinA: Still the Present for Chronic Migraine
2023 Baraldi, C.; Lo Castro, F.; Ornello, R.; Sacco, S.; Pani, L.; Guerzoni, S.
Oral Cannabinoid Preparations for the Treatment of Chronic Migraine: A Retrospective Study
2022 Baraldi, Carlo; Lo Castro, Flavia; Negro, Andrea; Ferrari, Anna; Cainazzo, Maria Michela; Pani, Luca; Guerzoni, Simona
Proteomic serum profile in menstrual-related and post menopause migraine
2020 Bellei, Elisa; Rustichelli, Cecilia; Bergamini, Stefania; Monari, Emanuela; Baraldi, Carlo; Lo Castro, Flavia; Tomasi, Aldo; Ferrari, Anna
Proteomic serum profile of female migraineurs
2019 Bellei, E; Bergamini, S; Monari, E; Rustichelli, C; Baraldi, C; Lo Castro, F; Tomasi, A; Ferrari, A
Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study
2020 Rustichelli, Cecilia; Bellei, Elisa; Bergamini, Stefania; Monari, Emanuela; Baraldi, Carlo; Castro, Flavia Lo; Tomasi, Aldo; Ferrari, Anna
Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review
2020 Rustichelli, Cecilia; Lo Castro, Flavia; Baraldi, Carlo; Ferrari, Anna
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Allopregnanolone serum levels in female migraineurs | 1-gen-2019 | Rustichelli, C.; Bellei, E.; Bergamini, S.; Monari, E.; Lo Castro, F.; Baraldi, C.; Cainazzo, M. M.; Tomasi, A.; Ferrari, A. | |
| Chronic migraine evolution after 3 months from erenumab suspension: real-world-evidence-life data | 1-gen-2022 | Guerzoni, S.; Baraldi, C.; Pensato, U.; Favoni, V.; Lo Castro, F.; Cainazzo, M. M.; Cevoli, S.; Pani, L. | |
| Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study | 1-gen-2021 | Rustichelli, Cecilia; Bellei, Elisa; Bergamini, Stefania; Monari, Emanuela; Lo Castro, Flavia; Baraldi, Carlo; Tomasi, Aldo; Ferrari, Anna | |
| OnabotulinumtoxinA: Still the Present for Chronic Migraine | 1-gen-2023 | Baraldi, C.; Lo Castro, F.; Ornello, R.; Sacco, S.; Pani, L.; Guerzoni, S. | |
| Oral Cannabinoid Preparations for the Treatment of Chronic Migraine: A Retrospective Study | 1-gen-2022 | Baraldi, Carlo; Lo Castro, Flavia; Negro, Andrea; Ferrari, Anna; Cainazzo, Maria Michela; Pani, Luca; Guerzoni, Simona | |
| Proteomic serum profile in menstrual-related and post menopause migraine | 1-gen-2020 | Bellei, Elisa; Rustichelli, Cecilia; Bergamini, Stefania; Monari, Emanuela; Baraldi, Carlo; Lo Castro, Flavia; Tomasi, Aldo; Ferrari, Anna | |
| Proteomic serum profile of female migraineurs | 1-gen-2019 | Bellei, E; Bergamini, S; Monari, E; Rustichelli, C; Baraldi, C; Lo Castro, F; Tomasi, A; Ferrari, A | |
| Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study | 1-gen-2020 | Rustichelli, Cecilia; Bellei, Elisa; Bergamini, Stefania; Monari, Emanuela; Baraldi, Carlo; Castro, Flavia Lo; Tomasi, Aldo; Ferrari, Anna | |
| Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review | 1-gen-2020 | Rustichelli, Cecilia; Lo Castro, Flavia; Baraldi, Carlo; Ferrari, Anna |